secwatch.observer — SEC 8-K summary
======================================

Issuer:     PFIZER INC (PFE)
CIK:        0000078003
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0000078003-24-000127
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyrus Taraporevala elected to Pfizer's Board of Directors effective June 27, 2024
--------------------------------------------------------------------------------

- Taraporevala, former President & CEO of State Street Global Advisors (2017-2022), joins Board.
- Appointed to Audit Committee and Compensation Committee immediately.
- Also serves on boards of Shell plc and Bridgepoint Group plc.
- Background includes roles at Fidelity, BNY Mellon, Legg Mason, Citigroup, and McKinsey.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/78003/000007800324000127/0000078003-24-000127-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/78003/000007800324000127/pfe-20240627.htm
  HTML page:      https://secwatch.observer/filing/0000078003-24-000127

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer